<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00316641</url>
  </required_header>
  <id_info>
    <org_study_id>DMR93-IRB-71</org_study_id>
    <nct_id>NCT00316641</nct_id>
  </id_info>
  <brief_title>The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe
      in the treatment of Hyperlipidemia Patients
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <condition>Hyperlipidemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lipid-lowing Tea</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 20-65 years;either sex

          -  Patient diagnosed with hyperlipidemia(fasting levels of TC&gt;=200mg/dL),or TG&gt;=200mg/dL
             but &lt;400mg/dL,or LDL-C&gt;=130mg/dL)

          -  Patient who has signed the informed consent form

        Exclusion Criteria:

          -  Patient with pregnancy (or child bearing potential),or in lactation

          -  Patient with any lipid regulating agents within 4 weeks prior to study period

          -  Patient currently taking concomitant medications, such as oral contraceptives, or any
             medical treatment capable of interfering with lipid metabolism(eg thiazides,
             β-blockers, cyclosporins, itraconazole erythromycin,and danazol)

          -  Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic
             syndrome, gall bladder disease, primary biliary cirrhosis.

          -  Patient with liver dysfunction (SGOT or SGPT&gt;2x ULN)

          -  Patient with renal insufficiency (serum creatinine&gt;1.3mg/dL)

          -  Patient with myocardial infarction,cerebrovascular disease,or major operations within
             6 months prior to the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Chia-I Tsai, V.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Medical University Hospital,Taichung,Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chia-I Tsai, V.S</last_name>
    <phone>886-4-22052121</phone>
    <phone_ext>5065</phone_ext>
    <email>josepho777@yahoo.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chia-I Tsai, MD</last_name>
      <phone>886-4-22052121</phone>
      <phone_ext>5065</phone_ext>
      <email>josepho777@yahoo.com.tw</email>
    </contact>
    <investigator>
      <last_name>Chia-I Tsai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2006</study_first_submitted>
  <study_first_submitted_qc>April 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2006</study_first_posted>
  <last_update_submitted>November 6, 2006</last_update_submitted>
  <last_update_submitted_qc>November 6, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

